International Journal of Hematology-Oncology and Stem Cell Research 2010. 4(1):23-27.

Prevalence of Minor β-thalassemia Based on RBC Indices among Final Suspected Individuals in Premarital Screening Program Referred to Genetic Laboratories
Alireza Moafi, Sadeg Valian, Zahra Nikyar, Mehrdad Zeinalian, Maryam Momenzadeh, Soheila Rahgozar

Abstract


Introduction:The current study evaluated the value of red blood cell (RBC) indices and the corresponding cut- off points for β-thalassemia control programs in Iran.
Materials and Methods:1,150 individuals (575 couples) with low RBC indices and normal hemoglobin A2 who had been referred to the Genetic Centre of Isfahan, were tested during pre-marital screening analyses, in the 2 year period, 2006-2008. β-thalassemia mutations were evaluated.
Results: β-thalassemia was identified in 67.8% of the cases with both mean corpuscular volume (MCV) less than 78fl and mean corpuscular hemoglobin (MCH) less than 26 pg. However, 4.1% of the individuals with  78≤ MCV≤ 80 tested positive for thalassemia. MCV showed a higher diagnostic reliability than MCH. However, the accompaniment of MCH<26 with MCV<78 increased the risk of thalassemia 35 times. A significant association was found between the prevalence of minor β-thalassemia and educational levels, race and familial relationships.
Conclusion: According to the results of this study, it seems that MCV=80fl can be used as a proper cut- off point for the screening of minor β-thalassemia. Although in the present study MCV was found to have a higher diagnostic reliability than MCH, MCH <26 along with MCV are very helpful indices for the counselor physician to estimate the risk of minor β-thalassemia more accurately.


Keywords


Minor β-Thalassemia; Screening; MCH; MCV; Thalassemia Preventing Program

Full Text:

PDF

References


Fallah MS, Samavat A, Zeinali S. Iranian National Program for the Prevention of Thalassemia and Prenatal Diagnosis: Mandatory Premarital Screening and Legal Medical Abortion. Prenat Diagn 2009; 29(13): 1285- 6.

Samavat A, Modell B. Iranian National Thalassaemia Screening Programme. Bmj 2004; 329 (7475): 1134- 7.

Al-Suliman A. Prevalence of beta-Thalassemia Trait in Premarital Screening in Al-Hassa, Saudi Arabia. Ann Saudi Med 2006; 26 (1): 14- 6.

Ma ES, Chan AY, Ha SY, et al. Thalassemia Screening Based on Red Cell Indices in the Chinese. Haematologica 2001; 86 (12): 1310- 1.

Leung TN, Lau TK, Chung T. Thalassaemia Screening in Pregnancy. Curr Opin Obstet Gynecol 2005; 17 (2): 129- 34.

Bencaiova G, Burkhardt T, Krafft A, et al. Screening for beta-Thalassaemia Trait in Anaemic Pregnant Women. Gynecol Obstet Invest 2006; 62 (1): 20- 7.

Mamtani M, Jawahirani A, Rughwani V, et al. Value of Mean Corpuscular Volume and Mean Corpuscular Haemoglobin in Screening for beta-Thalassaemia Trait. Acta Haematol 2006; 116 (3): 223- 5.

Law HY, Chee MK, Tan GP, et al. The Simultaneous Presence of alpha- and beta-Thalassaemia Alleles: a Pitfall of Thalassaemia Screening. Community Genet 2003; 6 (1): 14- 21.

Kotwal J, Saxena R, Choudhry VP, et al. Erythrocyte Indices for Discriminating Thalassaemic and non- Thalassaemic Microcytosis in Indians. Natl Med J India 1999; 12 (6): 266- 7.

Kiss TL, Ali MA, Levine M, et al. An Algorithm to Aid in the Investigation of Thalassemia Trait in Multicultural Populations. Arch Pathol Lab Med 2000; 124 (9): 1320- 3.

Pignati CB GR. Thalassemia and Related Disorders- Quantitative Disorders of Hemoglobin. In: Foerester J RMG, Paraskevas F, Glader B, et al GreerJ P, editor. Wintrobe's Clinical Hematology. 12 ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 1083- 1131.

Karimi M, Rasekhi AR. Efficiency of Premarital Screening of beta-Thalassemia Trait Using MCH Rather than MCV in the Population of Fars Province, Iran. Haematologia (Budap) 2002; 32 (2): 129- 33.

Farid M, Farid S, Alamgir M, et al. Role of non- Government Organization in Improving Socio-economic and Physical Conditions of the Patients of Thalassemia and Hemophilia. J. Applied Sci. 2002; 2: 579- 583.

Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: Epidemiology, Prevention, and Management. J Pediatr Hematol Oncol 2007; 29 (4): 233- 8.

Habibzadeh F YM, Merat A, Haghshenas M. Thalassemia in Iran; an Overview. Arch Iran Med 1998; 1: 27- 33.

Pranpanus S, Sirichotiyakul S, Srisupundit K, et al. Sensitivity and Specificity of Mean Corpuscular Hemoglobin (MCH): for Screening alpha-Thalassemia-1 Trait and beta- Thalassemia Trait. J Med Assoc Thai 2009; 92 (6): 739- 43.

Lafferty JD, Crowther MA, Ali MA, et al. The Evaluation of Various Mathematical RBC Indices and their Efficacy in Discriminating between Thalassemic and non-Thalassemic Microcytosis. Am J Clin Pathol 1996; 106 (2): 201- 5.

Sirichotiyakul S, Maneerat J, Sa-nguansermsri T, et al. Sensitivity and Specificity of Mean Corpuscular Volume Testing for Screening for alpha-Thalassemia-1 and beta- Thalassemia Traits. J Obstet Gynaecol Res 2005; 31 (3): 198- 201.

Melo MR, Purini MC, Cancado RD, et al. [The Use of Erythrocyte (RBC) Indices in the Differential Diagnosis of Microcytic Anemias: Is it an Approach to be Adopted?]. Rev Assoc Med Bras 2002; 48 (3): 222- 4.

Sirdah M, Tarazi I, Al Najjar E, et al. Evaluation of the Diagnostic Reliability of Different RBC Indices and Formulas in the Differentiation of the beta-Thalassaemia Minor from Iron Deficiency in Palestinian Population. Int J Lab Hematol 2008; 30 (4): 324- 330.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.